Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20


New tools for pathology: a user's review of a highly multiplexed method for in situ analysis of protein and RNA expression in tissue.

Decalf J, Albert ML, Ziai J.

J Pathol. 2019 Apr;247(5):650-661. doi: 10.1002/path.5223. Epub 2019 Feb 20. Review.


Multimarker risk stratification approach at multiple sclerosis onset.

Fernández-Paredes L, Casrouge A, Decalf J, de Andrés C, Villar LM, Pérez de Diego R, Alonso B, Álvarez Cermeño JC, Arroyo R, Tejera-Alhambra M, Navarro J, Oreja-Guevara C, López Trascasa M, Seyfferth A, García Martínez MA, Álvarez Lafuente R, Albert ML, Sánchez-Ramón S.

Clin Immunol. 2017 Aug;181:43-50. doi: 10.1016/j.clim.2017.05.019. Epub 2017 May 31.


Sensing of HIV-1 Entry Triggers a Type I Interferon Response in Human Primary Macrophages.

Decalf J, Desdouits M, Rodrigues V, Gobert FX, Gentili M, Marques-Ladeira S, Chamontin C, Mougel M, Cunha de Alencar B, Benaroch P.

J Virol. 2017 Jul 12;91(15). pii: e00147-17. doi: 10.1128/JVI.00147-17. Print 2017 Aug 1.


Detection of interferon alpha protein reveals differential levels and cellular sources in disease.

Rodero MP, Decalf J, Bondet V, Hunt D, Rice GI, Werneke S, McGlasson SL, Alyanakian MA, Bader-Meunier B, Barnerias C, Bellon N, Belot A, Bodemer C, Briggs TA, Desguerre I, Frémond ML, Hully M, van den Maagdenberg AMJM, Melki I, Meyts I, Musset L, Pelzer N, Quartier P, Terwindt GM, Wardlaw J, Wiseman S, Rieux-Laucat F, Rose Y, Neven B, Hertel C, Hayday A, Albert ML, Rozenberg F, Crow YJ, Duffy D.

J Exp Med. 2017 May 1;214(5):1547-1555. doi: 10.1084/jem.20161451. Epub 2017 Apr 18.


Ultrasensitive HIV-1 p24 Assay Detects Single Infected Cells and Differences in Reservoir Induction by Latency Reversal Agents.

Passaes CPB, Bruel T, Decalf J, David A, Angin M, Monceaux V, Muller-Trutwin M, Noel N, Bourdic K, Lambotte O, Albert ML, Duffy D, Schwartz O, Sáez-Cirión A.

J Virol. 2017 Feb 28;91(6). pii: e02296-16. doi: 10.1128/JVI.02296-16. Print 2017 Mar 15.


Comment on "NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis".

Decalf J, da Silva RB, Werneke S, Albert ML.

Sci Transl Med. 2016 Jul 27;8(349):349le1. doi: 10.1126/scitranslmed.aaf9121.


Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post-translational modification: prospective placebo-controlled clinical studies.

Decalf J, Tarbell KV, Casrouge A, Price JD, Linder G, Mottez E, Sultanik P, Mallet V, Pol S, Duffy D, Albert ML.

EMBO Mol Med. 2016 Jun 1;8(6):679-83. doi: 10.15252/emmm.201506145. Print 2016 Jun.


Dynamic Changes of Post-Translationally Modified Forms of CXCL10 and Soluble DPP4 in HCV Subjects Receiving Interferon-Free Therapy.

Meissner EG, Decalf J, Casrouge A, Masur H, Kottilil S, Albert ML, Duffy D.

PLoS One. 2015 Jul 16;10(7):e0133236. doi: 10.1371/journal.pone.0133236. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0139818.


Establishment of murine gammaherpesvirus latency in B cells is not a stochastic event.

Decalf J, Godinho-Silva C, Fontinha D, Marques S, Simas JP.

PLoS Pathog. 2014 Jul 31;10(7):e1004269. doi: 10.1371/journal.ppat.1004269. eCollection 2014 Jul.


The ABCs of viral hepatitis that define biomarker signatures of acute viral hepatitis.

Duffy D, Mamdouh R, Laird M, Soneson C, Le Fouler L, El-Daly M, Casrouge A, Decalf J, Abbas A, Eldin NS, Fontes M, Abdel-Hamid M, Mohamed MK, Rafik M, Fontanet A, Albert ML.

Hepatology. 2014 Apr;59(4):1273-82. doi: 10.1002/hep.26901. Epub 2014 Feb 18.


Dynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connections.

Gaudin R, Berre S, Cunha de Alencar B, Decalf J, Schindler M, Gobert FX, Jouve M, Benaroch P.

PLoS One. 2013 Jul 29;8(7):e69450. doi: 10.1371/journal.pone.0069450. Print 2013.


OatA, a peptidoglycan O-acetyltransferase involved in Listeria monocytogenes immune escape, is critical for virulence.

Aubry C, Goulard C, Nahori MA, Cayet N, Decalf J, Sachse M, Boneca IG, Cossart P, Dussurget O.

J Infect Dis. 2011 Sep 1;204(5):731-40. doi: 10.1093/infdis/jir396.


Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV.

Casrouge A, Decalf J, Ahloulay M, Lababidi C, Mansour H, Vallet-Pichard A, Mallet V, Mottez E, Mapes J, Fontanet A, Pol S, Albert ML.

J Clin Invest. 2011 Jan;121(1):308-17. doi: 10.1172/JCI40594. Epub 2010 Dec 22.


Cutting edge: adaptive versus innate receptor signals selectively control the pool sizes of murine IFN-γ- or IL-17-producing γδ T cells upon infection.

Ribot JC, Chaves-Ferreira M, d'Orey F, Wencker M, Gonçalves-Sousa N, Decalf J, Simas JP, Hayday AC, Silva-Santos B.

J Immunol. 2010 Dec 1;185(11):6421-6425. doi: 10.4049/jimmunol.1002283. Epub 2010 Oct 29.


Circulating plasmacytoid dendritic cells in acutely infected patients with hepatitis C virus genotype 4 are normal in number and phenotype.

Mansour H, Laird ME, Saleh R, Casrouge A, Eldin NS, El Kafrawy S, Hamdy M, Decalf J, Rosenberg BR, Fontanet A, Abdel-Hamid M, Mohamed MK, Albert ML, Rafik M.

J Infect Dis. 2010 Dec 1;202(11):1671-5. doi: 10.1086/656777. Epub 2010 Oct 19.


Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with buruli ulcer disease.

Phillips R, Sarfo FS, Guenin-Macé L, Decalf J, Wansbrough-Jones M, Albert ML, Demangel C.

J Infect Dis. 2009 Dec 1;200(11):1675-84. doi: 10.1086/646615.


Plasmacytoid dendritic cells move down on the list of suspects: in search of the immune pathogenesis of chronic hepatitis C.

Albert ML, Decalf J, Pol S.

J Hepatol. 2008 Dec;49(6):1069-78. doi: 10.1016/j.jhep.2008.09.002. Epub 2008 Sep 29. Review.


Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection.

Neveu B, Debeaupuis E, Echasserieau K, le Moullac-Vaidye B, Gassin M, Jegou L, Decalf J, Albert M, Ferry N, Gournay J, Houssaint E, Bonneville M, Saulquin X.

Hepatology. 2008 Sep;48(3):713-22. doi: 10.1002/hep.22379.


Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients.

Decalf J, Fernandes S, Longman R, Ahloulay M, Audat F, Lefrerre F, Rice CM, Pol S, Albert ML.

J Exp Med. 2007 Oct 1;204(10):2423-37. Epub 2007 Sep 24.


Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone.

Coutanceau E, Decalf J, Martino A, Babon A, Winter N, Cole ST, Albert ML, Demangel C.

J Exp Med. 2007 Jun 11;204(6):1395-403. Epub 2007 May 21.

Supplemental Content

Loading ...
Support Center